Oxalic Acid

Oxalic Acid

SCHEMBL7563539

CCOC(=O)COc1ccc2c(c1)CCCC(NC[C@H](O)COc1ccccc1)C2.O=C(O)C(=O)O

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 1/20 0.61
KDM4E B2RXH2 4/20 0.51
LMNA P02545 4/20 0.51
KMT2A Q03164 3/20 0.51
MEN1 O00255 2/20 0.51
GMNN O75496 1/20 0.51
PMP22 Q01453 1/20 0.51
ALDH1A1 P00352 4/20 0.51
NPY5R Q15761 1/20 0.47
NPY1R P25929 1/20 0.46
HTT P42858 2/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
TSHR P16473 1/20 0.46
CYP2C19 P33261 1/20 0.46
THPO P40225 1/20 0.46
NPC1 O15118 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7568590 0.98 ADRB3 (0.63) ADRB3KDM4ELMNAKMT2AMEN1
SCHEMBL7563231 0.95 ADRB3 (0.68) ADRB3KDM4ELMNAKMT2AMEN1
SCHEMBL7570740 0.95 ADRB3 (0.68) ADRB3KDM4ELMNAKMT2AMEN1
SCHEMBL5143626 0.95 ADRB3 (0.68) ADRB3KDM4ELMNAKMT2AMEN1
SCHEMBL5143624 0.95 ADRB3 (0.68) ADRB3KDM4ELMNAKMT2AMEN1
SCHEMBL7563773 0.95 ADRB3 (0.68) ADRB3KDM4ELMNAKMT2AMEN1
Hydrochloric Acid SCHEMBL7562959 0.94 ADRB3 (0.67) ADRB3KDM4ELMNAKMT2AMEN1
Hydrochloric Acid SCHEMBL7565548 0.94 ADRB3 (0.67) ADRB3KDM4ELMNAKMT2AMEN1
Hydrochloric Acid SCHEMBL7564743 0.94 ADRB3 (0.67) ADRB3KDM4ELMNAKMT2AMEN1
Hydrochloric Acid SCHEMBL7566295 0.94 ADRB3 (0.67) ADRB3KDM4ELMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6391915-B2 ANTIULCER AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-05-21 US disclosed
US-20020006956-A1 Propanolamine derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020006956-A1 Propanolamine derivatives PNLIP, ADRB1, FABP2 ADRB3 7/4885KDM4E 3737/4885LMNA 2259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.